IPNAF yields 2.14% · PFE yields 6.20%● Live data
📍 IPNAF pulled ahead of the other in Year 1
Combined, IPNAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IPNAF + PFE for your $10,000?
Information Planning CO., LTD. provides system consulting services primarily for financial institutions. It offers credit risk management related products, including comprehensive financial statement registration solution, collateral/real estate management, self-assessment/delinquency management, and risk measurement solutions. The company also provides loan related products, such as loan approval support, contract create support, benchmark aggregation, business feasibility evaluation support, and public relations support map systems; general affairs/accounting related products comprising fixed asset management, settlement business support, anti-social forces information check, investment management, expense payment office work support, and securities management systems; and tax/accounting related products, such as real-time connection and fixed asset management systems. In addition, it engages in the real estate leasing and management activities; and provision of development, planning, and system data input agency services. Information Planning CO., LTD. was incorporated in 1986 and is headquartered in Osaka, Japan.
Full IPNAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.